Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

First Name

Last Name

Company

E-mail

1

Frederik

 van der Broek

Elsevier

f.broek@elsevier.com 

2

Jignesh

Bhate

Molecular Connections

jignesh@molecularconnections.com 

3

Richard

Bishop

BMS

Richard.Bishop@bms.com

4

Evan

Bolton

NCBI

bolton@ncbi.nlm.nih.gov 

5

Jeremy

Burrows

MMV

burrowsj@mmv.org 

6

Matan

Burstin

Clarivate

Matan.Burstin@Clarivate.com

7

Whitney

Smith

Collaborative Drug Discovery

whitney@collaborativedrug.com

8

Frank

Cole

Collaborative Drug Discovery

frank@collaborativedrug.com

9

Daniel

Cooper

University of Miami

djc183@med.miami.edu

10

Devendra

Deshmukh

Riffyn

ddeshmukh@riffyn.com

11

Isabella

Feierberg

AZ

isabella.feierberg@astrazeneca.com 

12

Natalie 

Franklin

Lilly

nfranklin@lilly.com 

13

Anna

Gaulton

EMBL/EBI

anna.gaulton@pistoiaalliance.org

14

Vibhor

Gupta

Pangae Data AI

vgupta@pangaeadata.ai

15

Timothy

Hoctor16

Elsevier

T.Hoctor@elsevier.com 

Samantha

Jeschonek

Collaborative Drug Discovery

sjeschonek@collaborativedrug.com
16
17

Dave

King

Bayer

dave.king@bayer.com 

18

Hande

Kucuk-McGinty

Collaborative Drug Discovery

Hande@collaborativedrug.com

19
17

Andrew

Leach

EMBL/EBI

arl@ebi.ac.uk

20

Nick

Lynch

Pistoia Alliance

nick.lynch@pistoiaalliance.org

2122
18

Derek

Marren

Lilly

marren_derek@lilly.com 

23
19

Christopher

McKenna

Clarivate

christopher.mckenna@clarivate.com 

24
20

Angeli

Moeller

Bayer

angeli.moeller@bayer.com 

21

Mark 

Musen

Stanford University

musen@stanford.edu
22
2526

Nolan

Nichols

Roche

nichols.nolan@gene.com 

23

Carmen

Nitsche

Pistoia Alliance

Carmen.Nitsche@pistoiaalliance.org

2728
24

John

Overington

Medicines Discovery Catapult

jpo@md.catapult.org.uk 

29
25

George

Papadatos

GSK 

George.x.Papadatos@gsk.com 

26

Filip

Pattyn

Ontoforce

filip.pattyn@ontoforce.com

3031
27

Fabien

Pernot

Novartis

Fabien.pernot@novartis.com 

32
28

Tom

Plasterer

AZ

Tom.Plasterer@astrazeneca.com 

33
29

Timea

Polgar

Envision Biotechnology

timea.polgar@envisionbiotechnology.com

34
30

Jane

Reed

Linguamatics

jane.reed@linguamatics.com 

35
31

Martin

Romacker

Roche

martin.romacker@roche.com 

36
32

Rosalind

Sankey

Elsevier

r.sankey@elsevier.com

33

Stephan

Schurer

University of Miami

stephan.schurer@gmail.com 

3738
34

Anosha

Siripala

Novartis

anosha.siripala@novartis.com

35

Simon

Smith

Bench Sci

simon@benchsci.com

39

Frederik

van den Broek

Elsevier

f.broek@elsevier.com

4041
36

Dana

Vanderwall

BMS

Dana.Vanderwall@bms.com

Schroedinger

37

Dusica

Vidovic

University of Miami

dvidovic@med.miami.edu

4243
38

Scott

Wagers

Omnisoft

scottwagers@biosciconsulting.onmicrosoft.com 

39

Paul

Whitehead

BMS

Paul.Whitehead@bms.com 

4445
40

Kees

van Bochove

The Hyve

kees.vanbochove@pistoiaalliance.org

41

Mark

Hughes

Biorelate

mark.hughes@biorelate.com

46
42

Darren

Hoyland

Biorelate

darren.hoyland@biorelate.com

4748
43

Adrian

Fowkes

Lhasa LTD

Adrian.Fowkes@lhasalimited.org

44

Will

Drewe

Lhasa LTD

Will.Drewe@lhasalimited.org

45

Jake

Rubenstein

Tellic

46

Jacob

Bode

Eurofins

47

Ellen

Berg

Eurofins

48

Sean

Liu

Takeda

49

Rama

Balakrishnan

Genentech (Roche)

50

Steven

Penn

Pfizer

51

Timothy

Ikeda

AstraZeneca

52

Thomas

Liener

Pistoia Alliance

53

Jason

Harris

Collaborative Drug Discovery

54

Gabriel

Backiananthan

Novartis

55

Pablo

Porras Millan

AstraZeneca